Sacral Nerve Stimulation Market Size, Share & Trends Analysis Report By Product, By Application (Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others), By Region, And Segment Forecasts, 2024 - 2030

Sacral Nerve Stimulation Market Trends

The global sacral nerve stimulation market size was valued at USD 1.60 billion in 2023 and is projected to grow at a CAGR of 11.5% from 2024 to 2030. This market growth is attributed to the increasing rates of overactive bladder conditions and the incidence of urge incontinence, including UTIs. In addition, advancements in technology and increased awareness of SNS as an effective treatment option enhance its adoption. The market is also supported by a growing number of clinical studies and innovations from manufacturers aimed at improving device efficacy and safety.

Sacral nerve stimulation (SNS) is a therapeutic technique that delivers electrical impulses to the sacral nerves, which control bladder and bowel functions. This procedure is typically performed in two stages: an initial trial phase with a temporary lead to assess effectiveness, followed by permanent implantation of a neurostimulator if successful. SNS is primarily used to treat conditions such as urinary and fecal incontinence, enhancing communication between the brain and pelvic nerves to improve control over these functions.

According to reports published at the National Library of Medicine in November 2023, the U.S. had over 626,000 hospital admissions in the year for complicated UTIs, accounting for 1.8% of overall annual hospitalizations, with 80% being non-catheter related. These statistics are a clear indication of a serious issue to be worked on and allow the SNS market players to increase their market share due to the vital role of SNS devices in the treatment of UTIs, such as modulating nerve signals between the brain and pelvic organs, including the bladder, assists in managing OAB symptoms, and other utilizations thus expected to increase the demand for the devices which is expected to market growth in upcoming years.

Moreover, the growth in digital health platforms and heavy investments by healthcare organizations are leading to technological advancement in SNS devices, which offer various benefits such as wireless communication to track patients' progress, miniaturized devices that are less invasive and utilized in minimal surgical intervention, customized programming options that assist healthcare providers to customize the machines according to patients condition, and integration of AI and data analytics which allows predictive treatment outcomes based on historical data. This technological advancement has enhanced the treatment process, resulting in better outcomes and assuring patients to avail of the treatment, thus expected to grow the market significantly in the upcoming years.

Application Insights

Urinary and fecal incontinence led the market and accounted for the largest revenue share of 29.5% in 2023 attributed to the prevalence of urinary incontinence (UI) and fecal incontinence (FI), especially in the geriatric population and women, increasing recognition for SNS as an effective treatment for the UI and FI leading to growing demand for an increasing number of treatments lead to favorable reimbursement policies, strategic collaboration between gastroenterologists, physical therapists, urologists, and other specialists to integrate SNS with a multidisciplinary approach for UI and FI treatments are enhancing the treatment procedure with better outcomes.

The urge Incontinence is expected to grow at a CAGR of 11.7% over the forecast period attributed to the Increasing prevalence of urinary incontinence, particularly among the aging population. In addition, rising awareness of SNS as an effective treatment option enhances market demand. Furthermore, the rising incidence of related conditions, such as overactive bladder and urinary tract infections, also fuels the need for innovative treatments in this sector.

Product Insights

The implantable SNS devices dominated the market and accounted for the largest revenue share of 87.5% in 2023 attributed to the increasing awareness of pelvic health issues and fecal incontinence, which encourages individuals to go for the treatment and increases the demand for this product; improved reimbursement policies, such as an increasing number of insurance providers, are enabling the patient to take the treatment, improved outcomes after the treatment which increases its demand in healthcare organizations, increasing R&D funding leading to growth in the applications of this device beyond incontinence such as chronic pelvic pain syndromes and sexual dysfunctions.

External SNS devices are anticipated to grow at the fastest CAGR of 13.1% over the forecast years driven by the increasing geriatric population in many countries, which increases the incidence of pelvic floor dysfunctions, driving the demand for external SNS devices for non-invasive treatments. Furthermore, increasing competition in this segment leads to strategic partnerships and collaborations, which result in innovations and cost-effective products to gain an advantage and increase market share, eventually growing the segment significantly.

Regional Insights

The North America sacral nerve stimulation (SNS) market dominated the global market and accounted for the largest revenue share of 59.5% in 2023 driven by the rising demand for minimally invasive treatments, as SNS offers less invasive alternatives for conditions such as OAB and fecal incontinence. This supportive regulatory environment facilitates faster approval for advanced medical technologies and increases awareness about urinal and fecal dysfunctions among patients and healthcare professionals through educational campaigns.

U.S. Sacral Nerve Stimulation Market Trends

The sacral nerve stimulation market in the U.S. dominated the North American market with a share of 85.7% in 2023 attributed to the strategic collaborations and partnerships between healthcare providers and research institutions, leading to market innovations. In addition, increasing the prevalence of urinary and fecal incontinence, predominantly in women, technological advancement in devices with enhanced features such as improved battery life, miniaturization, and other features are urging healthcare providers and patients.

The Canada sacral nerve stimulation market is expected to grow at the fastest CAGR in North America over the forecast period. The growth of the market in the country is influenced by patient-centric approaches that improve treatment quality and result in better outcomes. This leads to an increasing number of treatments, thus significantly increasing the demand for the product and the market. Moreover, research and development initiatives to improve the effectiveness of the SNS in various applications are also playing a vital role in shaping the country's market.

Asia Pacific Sacral Nerve Stimulation Market Trends

The sacral nerve stimulation market in Asia Pacific is anticipated to grow at a CAGR of 13.1% over the forecast period driven by improved healthcare infrastructure, which increases access to specialized medical devices, and the rising disposable income of many countries in the region, which increases the affordability of therapy and surgery procedures. Thus, product demand increases and the region's market grows significantly.

The China sacral nerve stimulation market held a significant revenue share in 2023 owing to the increasing prevalence of urinary and fecal incontinence due to the increasing geriatric population and lifestyle choices leading to rising cases of these diseases and growing awareness and acceptance of advanced treatment options, which encourages individuals suffering from these diseases to seek treatment.

Europe Sacral Nerve Stimulation Market Trends

The sacral nerve stimulation market in Europe is expected to witness substantial growth over the projected years, owing to the growing awareness and acceptance among healthcare professionals and patients about the benefits of SNS therapy. In addition, regulatory bodies' increasing recognition of the importance of neuromodulation therapies is increasing the demand for new medical technologies such as SNS devices.

The UK sacral nerve stimulation market is expected to grow significantly over the forecast years due to collaboration between manufacturers and healthcare providers to provide enhanced education about the therapies among citizens. The country's senior population is increasing, which leads to growing cases of OAB and fecal incontinence. In addition, technological advancements and increased awareness of SNS as an effective treatment option further enhance its adoption. Favorable government initiatives and reimbursement schemes also expand the market, encouraging more patients to seek this innovative therapy.

Key Sacral Nerve Stimulation Company Insights

Some of the key companies in the sacral nerve stimulation market include Medtronic, Axonics, Inc., and many others. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies. 

• Medtronic offers products such as INTERSTIM, which is comprised of implanted electrical pacemakers that enhance the electrical stimulation of the sacral nerve.

• Axonics, Inc. offers a diversified portfolio of products and services, such as consultation with specialists, easy test options, Axonics F-15 recharge-free devices for safely undergoing full-body MRI scans, and many others.

Recent Developments

• In January 2024, Boston Scientific announced its definitive agreement to acquire Axonics, Inc. for approximately USD 3.4 billion. This acquisition aimed to enhance Boston Scientific's Urology business by integrating Axonics' innovative devices for treating urinary and bowel dysfunction.

Sacral Nerve Stimulation Market Report Scope

Global Sacral Nerve Stimulation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sacral nerve stimulation market report based on product, application, and region.

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Implantable SNS Devices

  • External SNS Devices

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Urinary and Fecal Incontinence

  • Chronic Anal Fissure

  • Urge Incontinence

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Singapore

  • Latin America

    • Brazil

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • Saudi Arabia

    • UAE

    • South Africa